A Phase 1, Randomized, Double-blind, Vehicle And Active Comparator-controlled, Psoriasis Plaque Test Study To Assess Safety, Tolerability, And Psoriatic Skin Infiltrate Thickness Following Repeated, Topical Doses Of Pf-06763809 Solution In Subjects With Mild To Moderate Chronic Plaque Psoriasis

Trial Profile

A Phase 1, Randomized, Double-blind, Vehicle And Active Comparator-controlled, Psoriasis Plaque Test Study To Assess Safety, Tolerability, And Psoriatic Skin Infiltrate Thickness Following Repeated, Topical Doses Of Pf-06763809 Solution In Subjects With Mild To Moderate Chronic Plaque Psoriasis

Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 13 Apr 2018

At a glance

  • Drugs PF 06763809 (Primary) ; Betamethasone; Calcipotriol
  • Indications Plaque psoriasis
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 23 Mar 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top